Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Craig R. Cohen, Michael R. Wierzbicki, Audrey L. French, Sheldon Morris, Sara Newmann, Hilary Reno, Lauri Green, Steve Miller, Jonathan Powell, Thomas Parks, Anke Hemmerling

Research output: Contribution to journalComment/debate

Abstract

(Abstracted from N Engl J Med 2020;382:1906-1915) Worldwide, 15% to 50% of women of reproductive age have bacterial vaginosis (BV) and are treated with an antibiotic agent. Within 3 months after treatment, the infection recurs in 20% to 75% of women.

Original languageEnglish
Pages (from-to)601-602
Number of pages2
JournalObstetrical and Gynecological Survey
Volume75
Issue number10
DOIs
StatePublished - Oct 1 2020

Fingerprint Dive into the research topics of 'Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis'. Together they form a unique fingerprint.

Cite this